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Abstract
Background  and  objectives:  The  aim  of  this  study  was  to  evaluate  the  effects  of  remote
ischemic  preconditioning  by  brief  ischemia  of  unilateral  hind  limb  when  combined  with
dexmedetomidine  on  renal  ischemia--reperfusion  injury  by  histopathology  and  active  caspase-3
immunoreactivity  in  rats.
Methods: 28  Wistar  albino  male  rats  were  divided  into  4  groups.  Group  I  (Sham,  n  =  7):  Laparo-
tomy and  renal  pedicle  dissection  were  performed  at  65th  minute  of  anesthesia  and  the  rats
were  observed  under  anesthesia  for  130  min.  Group  II  (ischemia--reperfusion,  n  =  7):  At  65th
minute  of  anesthesia  bilateral  renal  pedicles  were  clamped.  After  60  min  ischemia  24  h  of  reper-
fusion  was  performed.  Group  III  (ischemia--reperfusion  +  dexmedetomidine,  n  =  7):  At  the  ﬁfth
minute  of  reperfusion  (100  g/kg  intra-peritoneal)  dexmedetomidine  was  administered  with
ischemia--reperfusion  group.  Reperfusion  lasted  24  h.  Group  IV  (ischemia--reperfusion  +  remote
ischemic  preconditioning  +  dexmedetomidine,  n  =  7):  After  laparotomy,  three  cycles  of  ischemic
preconditioning  (10  min  ischemia  and  10  min  reperfusion)  were  applied  to  the  left  hind  limb  and
after  5  min  with  group  III.
Results:  Histopathological  injury  scores  and  active  caspase-3  immunoreactivity  were  signiﬁ-
cantly  lower  in  the  Sham  group  compared  to  the  other  groups.  Histopathological  injury  scores
in  groups  III  and  IV  were  signiﬁcantly  lower  than  group  II  (p  =  0.03  and  p  =  0.05).  Active  caspase-3
immunoreactivity  was  signiﬁcantly  lower  in  the  group  IV  than  group  II  (p  =  0.01)  and  there  was
no  signiﬁcant  difference  between  group  II  and  group  III  (p  =  0.06).
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Conclusions:  Pharmacologic  conditioning  with  dexmedetomidine  and  remote  ischemic  pre-
conditioning when  combined  with  dexmedetomidine  signiﬁcantly  decreases  renal  ischemia--
reperfusion  injury  histomorphologically.  Combined  use  of  two  methods  prevents  apoptosis  via
active  caspase-3.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Efeitos  de  dexmedetomidina  em  conjunto  com  o  pré-condicionamento  isquêmico
remoto  em  lesão  de  isquemia-reperfusão  renal  em  ratos
Resumo
Justiﬁcativa  e  objetivos:  Avaliar  os  efeitos  do  pré-condicionamento  isquêmico  remoto,  medi-
ante breve  isquemia  de  membro  posterior  unilateral,  em  combinac¸ão  com  dexmedetomidina  em
lesão  de  isquemia-reperfusão  renal  por  meio  de  histopatologia  e  imunorreatividade  da  caspase-3
ativa  em  ratos.
Métodos:  Foram  divididos  em  quatro  grupos  28  ratos  machos  albinos  Wistar.  Grupo  I  (Sham
[cirurgia controle],  n  =  7):  laparotomia  e  dissecc¸ão  do  pedículo  renal  foram  feitas  em  65
minutos  de  anestesia  e  os  ratos  foram  observados  sob  anestesia  por  130  minutos.  Grupo
II  (isquemia-reperfusão,  n  =  7):  no  65◦ minuto  de  anestesia,  os  pedículos  renais  bilaterais
foram pinc¸ados;  após  60  minutos  de  isquemia,  foi  feita  reperfusão  de  24  horas.  Grupo  III
(isquemia-reperfusão  +  dexmedetomidina,  n  =  7):  no  quinto  minuto  de  reperfusão,  dexmedeto-
midina  (100  mg/kg  intraperitoneal)  foi  administrada  ao  grupo  com  isquemia-reperfusão.  A
reperfusão  durou  24  horas.  Grupo  IV  (isquemia-reperfusão  +  pré-condicionamento  isquêmico
remoto  +  dexmedetomidina,  n  =  7):  após  a  laparotomia,  três  ciclos  de  pré-condicionamento
isquêmico (10  minutos  de  isquemia  e  10  minutos  de  reperfusão)  foram  aplicados  no  membro
posterior  esquerdo  e  depois  de  cinco  minutos  ao  grupo  III.
Resultados:  Os  escores  de  lesão  histopatológica  e  imunorreatividade  da  caspase-3  ativa  foram
signiﬁcativamente menores  no  grupo  Sham  em  comparac¸ão  com  os  outros.  Os  escores  de  lesão
histopatológica  dos  grupos  III  e  IV  foram  signiﬁcativamente  menores  do  que  os  do  II  (p  =  0,03  e
p  =  0,05).  A  imunorreatividade  da  caspase-3  foi  signiﬁcativamente  menor  no  grupo  IV  do  que  no
II  (p  =  0,01)  e  não  houve  diferenc¸a signiﬁcante  entre  os  grupos  II  e  III  (p  =  0,06).
Conclusões:  O  condicionamento  farmacológico  com  dexmedetomidina  e  o  pré-condicionamento
isquêmico remoto  em  combinac¸ão  com  dexmedetomidina  diminuem  de  modo  signiﬁcante  a
lesão  de  isquemia-reperfusão  renal  histomorfologicamente.  O  uso  combinado  dos  dois  métodos
previne  a  apoptose  via  caspase-3  ativa.
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Introduction
Ischemic  acute  renal  injury  is  a  clinical  syndrome  with  high
mortality and  morbidity.  Due  to  its  high  energy  requirements
and the  complex  network  of  the  renal  microvasculature,
the kidney  is  highly  sensitive  to  ischemia--reperfusion  (IR)
injury.1--4 The  mechanisms  of  renal  IR  injury  are  multifacto-
rial, including  hypoxia,  free-radical  damage,  and  local  and
systemic inﬂammatory  responses.5 Reperfusion  of  ischemic
renal tissue  induces  complex  cellular  conditions  and  the
death of  renal  cells,  due  to  apoptosis.6
Apoptosis  is  a  form  of  genetically  programmed  cell  death.
Two main  pathways  play  a  role  in  epithelial  apoptosis.  The
ﬁrst, known  as  the  extrinsic  or  death  receptor  pathway,
is stimulated  by  TNF--family  molecules  bound  to  CD95
ligand (Fas  ligand  =  CD95)  through  extracellular  signals.  This
pathway combines  with  the  second  pathway,  the  intrinsic
or mitochondrial  pathway,  via  caspase-3  activation,  which
includes cytochrome  c  and  the  Bcl-2  family  of  proteins,  and
together, they  enhance  apoptosis.7
t
b Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
Renal  tubular  cell  apoptosis  is  a  result  of  renal  injury
nd a  primary  and  major  contributor  to  IR  pathophysio-
ogy. Both  inﬂammation  and  apoptosis  coexist  in  renal  IR
njury. During  hypoxia,  caspase  activity  increases  as  a  result
f intracellular  Ca2+ accumulation.  Caspase  becomes  acti-
ated in  ischemic  tissues  and  is  an  indicator  of  cell  death.8
hese  changes,  which  can  be  observed  in  tubular  cells,  may
ause the  loss  of  brush  borders  of  proximal  tubular  cells,  and
pill out  from  the  basement  membrane  of  the  cells  into  the
ubular lumen,  with  eventual  tubule  obstruction.9,10
Among  the  methods  used  to  reduce  the  effects  of  IR
njury, remote  ischemic  preconditioning  (RIPC)  and  phar-
acological conditioning  are  the  most  commonly  used.11
n  reviewing  the  English-language  literature,  no  study  was
ound regarding  an  experimental  IR  model  to  investigate
he effects  of  using  pharmacological  conditioning  with
exmedetomidine administered  in  combination  with  RIPC.
Este é um artigo Open Access sob a licença de CC BY-NC-NDThe  aim  of  this  experimental  study  was  to  investigate
he renal  effects  of  unilateral  RIPC  administered  in  com-
ination with  dexmedetomidine  to  the  lower  extremity
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Tigure  1  Schematic  representation  of  the  experimental  pro-
ocol. I,  ischemia;  R,  reperfusion;  D,  deksmedetomidine.
istopathologically  and  to  evaluate  active  caspase-3
mmunoreactivity  in  a  rat  renal  IR  model.
aterials and methods
n  total,  28  adult  male  Wistar  albino  rats,  weighing
50--300 g,  were  used.  Until  the  beginning  of  the  research,
ats were  kept  at  room  temperature  (21--22 ◦C)  and  40--60%
elative humidity  on  a  12/12-h  light/dark  cycle  and  were
ed with  standard  pellet  diet  and  water  ad  libitum.  After
pproval by  the  Local  Ethics  Committee  for  Animal  Exper-
ments at  our  faculty,  the  study  was  carried  out  in  the
ultidisciplinary Laboratory  of  Animal  Experiments.  Anes-
hesia was  provided  with  50  mg/kg  ketamine  and  10  mg/kg
ylazine hydrochloride  administered  intraperitoneally  (ip).
fter anesthesia,  the  animals  were  divided  into  four  groups.
Group  I  (Sham,  n  =  7):  After  laparotomy,  the  left  and
ight renal  pedicles  were  exposed  at  the  65th  minute  of
nesthesia, and  rats  were  kept  under  anesthesia  for  130  min
ith no  other  intervention.
Group II  (IR,  n  =  7):  After  60  min  of  ischemia,  the  clamp
as removed  and  reperfusion  of  the  kidneys  was  allowed  for
4 h.
Group  III  (IR  +  dexmedetomidine,  n  =  7):  After  60  min
f ischemia,  the  clamp  was  removed  and  100  g/kg
exmedetomidine  (Precedex  100  g/2  mL,  Abbott  Laborato-
ies, IL,  USA)  was  administered  ip,  and  reperfusion  of  the
idneys was  allowed  for  24  h.
Group IV  (IR  +  RIPC  +  dexmedetomidine,  n  =  7):  Follow-
ng a  laparotomy,  after  5  min  of  RIPC,  and  a  subsequent
0 min  of  renal  ischemia,  the  clamp  was  removed  and
00 g/kg  dexmedetomidine  (Precedex  100  g/2  mL,  Abbott
aboratories) was  given  and  ﬁnally  24  h  of  reperfusion  was
erformed (Fig.  1).
Exposing  renal  pedicles  in  group  I,  and  initiating  ischemia
t the  65th  minute  of  anesthesia  in  groups  II  and  III,  was
ntended to  synchronize  all  the  groups  to  the  precondi-
ioning time  of  group  IV  and  to  standardize  the  start  of
he procedures.  Tissue  samples  were  obtained  after  24  h  of
eperfusion.To protect  the  rats  from  hypothermia,  the  operating
able was  heated  with  a  lamp  heater  throughout  the  study
nd rectal  body  temperature  was  measured  with  a  probe
nd maintained  at  3737.5 ◦C.  Hourly  subcutaneous  saline
(
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olution,  at  3  mL/kg  dosage,  was  administered  to  prevent
ehydration. During  the  waiting  time,  the  abdomen  was
losed with  a  moist  sterile  pad  and  surgical  forceps.  In  all
roups, the  left  kidneys  were  removed  under  anesthesia
or histomorphological  analyses  and  the  rats  were  sacri-
ced by  a  cardiac  puncture  exsanguination  at  the  end  of  the
tudy. The  kidneys  were  ﬁxed  in  10%  buffered  formalin  and
mbedded in  parafﬁn  wax,  cut  at  4--5  m,  and  stained  with
ematoxylin and  eosin  for  histological  studies  using  light
icroscopy.
enal  IR  model
he  right  and  left  renal  pedicles  were  exposed  after  laparo-
omy. Total  renal  ischemia  in  the  left  and  right  renal
edicles was  maintained  with  atraumatic  microvascular
lamp compression.  Adequate  occlusion  was  conﬁrmed  by  a
ack of  pulsation  in  the  renal  pedicles  and  presence  of  pallor
n the  kidneys.  After  the  ischemic  period,  the  microvascular
lamps were  removed  and  reperfusion  occurred.
IPC  model
or  the  tourniquet  effect  of  RIPC,  a  method  that  has  been
hown to  be  effective  by  perfusion  scintigraphy  and  a  laser
eter was  used.12,13 For  this  purpose,  the  left  hind  leg  of
he rat  was  bound  with  an  elastic  bandage  (1  cm  wide  and
0 cm  long)  at  the  groin,  applying  pressure  all  around.  Three
ycles of  10  min  of  ischemia  were  performed  followed  by
0 min  of  reperfusion  (65  min  total).  The  cessation  of  blood
ow was  conﬁrmed  using  a  laser  current  meter  (Laser  Flo
PM2, Vasamedic,  USA).
istomorphological  evaluation  of  renal  tissue
enal  tissue  sections  after  IR  were  evaluated  by  light
icroscopy by  two  histologists  blinded  to  the  animal  groups
n terms  of  structural  changes  in  proximal  tubules  (tubular
trophy, loss  of  tubular  brush  border,  vacuolization,  tubu-
ar dilatation,  cast  formation),  mononuclear  cells  (MNCs)
nﬁltration, interstitial  structural  changes,  renal  corpuscle
orphology, and  necrotic  and  apoptotic  cells.
The  cross-sectional  images  were  scored  semi-
uantitatively  in  terms  of  tubulointerstitial  damage.
coring was  conducted  as  follows:  0  =  not  at  all,  1  =  0--25%,
 =  26--45%,  3  =  46--75%,  and  4  =  76--100%.14
mmunohistochemical  methods
idney  tissues  were  ﬁxed  in  10%  buffered  formaldehyde,  and
fter routine  histological  follow-up  procedures,  parafﬁn-
mbedded kidney  tissues  were  cut  into  3-m  thick  sections
ith a  microtome  and  collected  on  poly-l-lysine-coated
lides.
Samples were  stored  in  the  oven  at  60 ◦C  for  12  h.
hen, a  rat-speciﬁc  anti-caspase-3  monoclonal  antibody
RB-10287-R7 Labvision)  was  used  to  assess  anti-caspase-3
mmunoreactivity.
Endogenous peroxidase  activity  was  blocked  using  a
% solution  of  hydrogen  peroxidase  in  alcohol.  Lysine
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Table  2  Immunohistochemical  injury  scores  of  the  groups.
Group  I  (n  =  7)
Sham
0.85 ±  0.37
Group II  (n  =  6)
IR
2.50 ±  0.54
Group III  (n  =  7)
IR  +  Dex
1.71  ±  0.75
Group IV  (n  =  7)
IR  +  RIPC  +  Dex
1.42 ±  0.53
Data are presented as mean ± SS.
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Figure  2  Mononuclear  cell  inﬁltration  scores  detected  by
renal histomorphological  examination.  *Comparison  of  the  IR
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sections  were  treated  with  anti-caspase-3  antibody  at  4 ◦C
overnight  and  then  incubated  with  a  biotinylated  secondary
antibody for  30  min.  After  application  of  the  Vector  Elite
ABC kit  (Vector  Laboratories  Inc.,  Burlingame,  USA),  the
antibody--biotin--avidin--peroxidase  complex  was  visualized
using 0.02%  3,3′-diaminobenzidine  solution.  Following
counterstaining with  Mayer’s  hematoxylin,  image  analysis
was performed.
The positive  staining  rate  was  evaluated  using  an  indica-
tor of  semi-quantitative  scoring  (1--4),  in  terms  of  density
and distribution.
Exclusion  criteria
Rats  in  need  of  resuscitation  were  excluded  from  the  study.
Statistical  analysis
The  SPSS  software  (ver.  15.0;  SPSS,  Chicago,  IL,  USA)
was used  for  statistical  analyses.  A  Kruskal--Wallis  analy-
sis of  variance  was  performed  to  analyze  the  data.  The
Mann--Whitney U-test  was  used  for  pair-wise  comparisons  of
the groups.  All  data  are  presented  as  means  ±  standard  devi-
ations. p  values  <0.05  were  considered  to  indicate  statistical
signiﬁcance.
Results
In  total,  28  rats  were  included  in  the  study  group.  One
rat in  the  IR  group  died  during  the  reperfusion  period,
and was  excluded  from  the  study.  Histomorphological  and
immunohistochemical injury  scores  of  the  study  groups  are
presented in  Tables  1  and  2.
Renal  histomorphological  injury  scores
MNC  inﬁltration.  Histomorphological  injury  scores  of  the
Sham group  were  signiﬁcantly  lower  than  those  of  the  IR
group (p  =  0.01).  Injury  scores  in  the  IR  group  were  signiﬁ-
cantly higher  than  in  the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groups
(p =  0.04  and  p  =  0.04,  respectively;  Fig.  2).Structural changes  in  the  proximal  tubules.  Histomor-
phological injury  scores  of  the  Sham  group  were  signiﬁcantly
lower than  those  of  the  IR,  IR  +  Dex,  and  IR  +  RIPC  +  Dex
groups (p  <  0.01,  p  =  0.02,  and  p  =  0.02,  respectively).  The  IR
(
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Table  1  Histomorphologically  injury  scores  of  the  groups.
MCI  
Group  I  (n  =  7)  Sham  0.14  ±  0.38  
Group II  (n  =  6)  IR  1.0  ±  0.63  
Group III  (n  =  7)  IR  +  Dex  0.28  ±  0.49  
Group IV  (n  =  7)IR  +  RIPC  +  Dex  0.28  ±  0.49  
pa 0.04b
Data are presented as mean ± SS.
MCI,  mononuclear cell inﬁltration; SCPD, structural changes in the pro
histological damage.
a Kruskal--Wallis test.
b p < 0.05: the signiﬁcant difference between the groups.roup with  the  Sham  group  (p  =  0.01). /= Comparison  of  the
R +  Dex  and  IR  +  RIPC  +  Dex  groups  with  the  IR  group  (p  <  0.05).
roup  displayed  signiﬁcantly  higher  scores  than  the  IR  +  Dex
nd  IR  +  RIPC  +  Dex  groups  (p  =  0.05  and  p  =  0.05,  respec-
ively), while  no  signiﬁcant  difference  was  found  between
he IR  +  Dex  and  IR  +  RIPC  +  Dex  groups  (p  =  1.00;  Fig.  3).
Glomerular changes.  Histomorphological  injury  scores  of
he Sham  group  were  signiﬁcantly  lower  than  those  of  the  IR
roup (p  =  0.04).  The  IR  group  displayed  signiﬁcantly  higher
cores than  the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groups  (p  =  0.04
nd p  =  0.04,  respectively),  while  no  signiﬁcant  difference
as found  between  the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groupsp =  1.00;  Fig.  4).
Total  histopathological  injury  score.  The  total  histomor-
hological injury  scores  of  the  Sham  group  were  signiﬁcantly
ower than  those  of  the  IR  group  (p  =  0.003).  Comparison
SCPD  CG  TSHD
0.0  ±  0.0  0.0  ±  0.0  0.28  ±  0.48
1.67  ±  0.82  0.50  ±  0.55  3.83  ±  2.22
0.71  ±  0.75  0.0  ±  0.0  1.42  ±  1.27
0.71  ±  0.75  0.0  ±  0.0  1.42  ±  1.61
0.00b 0.01b 0.008b
ximal tubules; CG, changes in glomerular; TSHD, total score of
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Figure  3  Tubular  change  injury  scores  detected  by  renal
histomorphological  examination.  *Comparison  of  the  IR,
IR +  Dex  and  IR  +  RIPC  +  Dex  groups  with  the  Sham  group
(p <  0.01). /= Comparison  of  the  IR  group  with  the  IR  +  Dex  and
IR +  RIPC  +  Dex  groups  (p  =  0.05).
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Figure  4  Glomerular  change  injury  scores  detected  by  renal
histomorphology. *Comparison  of  the  IR  group  with  the  Sham
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Figure  6  Renal  immunohistochemical  scoring.  *Comparison  of
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(p =  0.47;  Fig.  6).
No  cell  inﬁltration  or  loss  of  brush  border  was  observed  in
the sections  of  the  Sham  group  (Fig.  7A  and  B).  However,  in
Group I
P
GP
A
roup (p  <  0.01). /= Comparison  of  the  IR  group  with  the  IR  +  Dex
nd IR  +  RIPC  +  Dex  groups  (p  <  0.05).
f  the  IR  group  with  the  IR  +  Dex  and  IR  +  RIPC  +  Dex
roups showed  signiﬁcantly  higher  scores  than  the  IR  group
p = 0.03  and  p  =  0.05,  respectively),  while  the  IR  +  Dex
nd IR  +  RIPC  +  Dex  groups  showed  no  signiﬁcant  difference
p = 0.79;  Fig.  5).
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igure  5  Total  histopathological  injury  scores  detected  by
enal histomorphology.  *Comparison  of  the  IR  group  with  the
ham group  (p  <  0.01). /= Comparison  of  the  IR  group  with  the
R +  Dex  and  IR  +  RIPC  +  Dex  groups  (p  <  0.05).
F
Phe IR  group  with  the  Sham  group  (p  <  0.01). /= Comparison  of  the
R group  with  the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groups  (p  =  0.01).
Immunohistochemical  injury  score.  Immunohistochemi-
al staining  scores  of  the  IR  group  were  signiﬁcantly  higher
han in  the  Sham  group  (p  =  0.001).  No  statistically  signif-
cant difference  was  found  between  the  IR  and  IR  +  Dex
roups (p  =  0.06).
In  the  comparison  of  injury  scores  between  the
R +  RIPC  +  Dex  and  IR  groups,  those  of  the  IR  +  RIPC  +  Dex
roup were  signiﬁcantly  lower  (p  =  0.01).  The  injury  scores
f the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groups  did  not  differB
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P
G
igure  7  (A  and  B)  Sections  of  the  Sham  group.  G,  glomerular;
, the  proximal  tubule;  D,  the  distal  tubule:  the  brush  border.
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Figure  8  (A  and  B)  Sections  of  the  IR  group.  G,  glomerular;  P,
the proximal  tubule;  D,  the  distal  tubule,  (  )  accumulation
of proteinaceous  material  in  tubules,  ()  poured  into  the  lumen
of tubular  epithelial  cells.
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Figure  9  (A  and  B)  Sections  of  the  IR  +  Dex  group.  G,
glomerular; P,  the  proximal  tubule;  D,  the  distal  tubule,
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scores in  IR  injury.  In  both  groups,  all  the  scores  except
for tubular  changes  (p  =  0.05)  were  similar  to  the  scores
of the  Sham  group.  Signiﬁcant  decreases  were  detected  inthe  IR  group,  peritubular  MNC  inﬁltration,  more  prominent
in the  cortical  area,  and  loss  of  brush  border  of  the  proximal
tubule cells,  tubular  atrophy,  tubular  dilation,  and  vacuola-
tion were  observed.  In  some  of  the  tubules,  proteinaceous
material accumulation,  together  with  caste  formation  and
cell debris  in  the  tubule  lumen,  were  observed  (Fig.  8A  and
B).
In the  IR  +  Dex  group,  loss  of  the  brush  border  of  the
tubule cells,  tubular  atrophy,  tubular  dilatation,  vacuoliza-
tion, and  proteinaceous  material  accumulation  and  cell
debris in  the  tubule  lumen  were  observed,  albeit  to  a  lesser
extent than  in  the  IR  group  (Fig.  9A  and  B).
Compared  with  the  IR  group,  the  IR  +  RIPC  +  Dex  group
displayed tubular  atrophy,  tubular  dilatation,  vacuolization,
proteinaceous material  accumulation  and  cell  debris  in  the
lumen of  the  tubules,  and  loss  of  the  brush  border  of  the
tubule cells,  albeit  to  a  lesser  extent.  However,  compared
with the  IR  +  Dex  group,  tubular  changes  were  less  marked
(Fig. 10A  and  B).
Immunohistochemical staining  intensity  was  increased  in
the active  caspase-3-positive  cells  of  the  IR  group  compared
with the  Sham  group,  while  it  was  decreased  in  the  cells
of the  IR  +  Dex  and  IR  +  RIPC  +  Dex  groups  compared  with  the
IR group.  Staining  intensity  in  the  active  caspase-3-positive
cells of  the  IR  + RIPC  +  Dex  group  was  decreased  compared
with the  IR  +  Dex  group  (Fig.  11). a )  accumulation  of  proteinaceous  material  to  be  reduced
ompared to  other  groups.
iscussion
cute  renal  failure  occurring  as  a  result  of  ischemia  may
e due  to  hypotension,  hypovolemia,  and  hypoperfusion
econdary to  dehydration  as  well  as  IR  damage  in  major  car-
iothoracic, vascular,  and  transplant  surgeries.15--18 IR  injury
s one  of  the  most  common  causes  of  perioperative  acute
enal failure.18
Methods  such  as  RIPC  and  pharmacological  conditioning
ith dexmedetomidine,  which  are  used  to  prevent  or  treat
enal IR  injury,  have  been  shown  to  have  positive  effects  in
erms of  IR  injury  in  many  previous  studies.11
In  a literature  search,  we  found  no  study  that  had  eval-
ated the  effects  of  combining  these  two  methods  for  IR
njury. This  experimental  study,  using  a  rat  model  of  renal
R, compared  the  effects  of  using  dexmedetomidine  alone
r RIPC  in  combination  with  dexmedetomidine  against  renal
poptosis, assessing  using  caspase-3  immunoreactivity  and
istopathological injury  scores.
According  to  our  results,  dexmedetomidine  used  alone
r in  combination  with  RIPC  signiﬁcantly  reduced  MNC
nﬁltration, glomerulotubular  changes,  and  total  damagective caspase-3  immunoreactivity  in  the  dexmedetomidine
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Figure  10  (A  and  B)  Sections  of  the  IR  +  RIPC  +  Dex  group.
G, glomerular;  P,  proximal  tubule;  D,  distal  tubule,  and
( )  accumulation  of  proteinaceous  to  be  reduced  compared
to other.
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Figure  11  Active  caspase-3  immunohistochemistry  experimental
(C)  IR  +  Dex,  and  (D)  IR  +  RIPC  +  Dex  active  caspase-3  immunosta
D)  Sections  of  the  positive  active  caspase-3  immunostaining  were  o
decreased.E.  Bagcik  et  al.
ombined  with  RIPC  group,  suggesting  that  apoptosis,  a
ajor pathway  of  IR  injury,  could  be  reduced  or  prevented
y this  combination.
Various periods  of  ischemia  and  reperfusion  were  used
n renal  IR  injury  models  in  many  studies.19--22 The  critical
schemic period  is  dependent  on  the  organ,  and  ischemia
asting more  than  5  min  for  the  brain,  and  15--20  min  for  the
iver and  kidney  may  cause  neuronal  death  and  infarction.23
illiams  et  al.20 investigated  the  effects  of  IR  injury  in
lood and  tissue  samples  obtained  after  reperfusion  follow-
ng 45  min  of  renal  ischemia,  and  reported  that  renal  IR
njury occurred  earliest,  at  the  fourth  hour  and  peaked  at
4 h.
Organ-protective  effects  of  dexmedetomidine  against  IR
amage have  been  shown  in  many  tissues,  such  as  the  brain,
eart, and  kidneys.24--27 The  effects  of  dexmedetomidine
n rat  renal  IR  injury  were  investigated  by  Kocog˘lu  et  al.19
hese  researchers  reported  a signiﬁcant  decrease  in  scores
or histopathological  injury,  detected  at  the  45th  minute
fter ip  administration  of  100  g/kg  dexmedetomidine  at
he beginning  of  reperfusion.  In  our  study,  with  the  same
ose of  dexmedetomidine  administered  at  the  beginning
f reperfusion,  a  renoprotective  effect  was  achieved,  as
videnced by  signiﬁcant  reductions  in  the  histological  injury
cores. This  renoprotective  effect  was  found  not  only  during
he early  period  after  reperfusion  injury  but  it  continued,
ven at  24  h,  which  was  considered  the  peak  of  IR  injury.20
Although  the  mechanism  underlying  the  protective  effect
f dexmedetomidine  in  renal  IR  is  unclear,  it  is  considered
o increase  renal  blood  ﬂow  and  glomerular  ﬁltration  by
educing the  release  of  noradrenaline.28
Villela  et  al.29 reported  that  low-dose  dexmedetomidine
dministration  in  anesthetized  dogs  reduced  the  urinary
smolality and  plasma  vasopressin  level  and  caused  free-
ater diuresis.  In  patients  who  had  no  renal  disease  but
B
D
 groups  of  the  sectional  images  of  stained.  (A)  Sham,  (B)  IR,
ining  indicate  positive  proximal  tubule  epithelial  cells.  (C  and
bserved  in  the  proximal  tubule  epithelial  cells  in  the  B  group
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RDexmedetomidine  with  remote  ischemic  preconditioning  on
experienced  thoracic  surgery,  by  administering  an  infusion
of dexmedetomidine,  Frumento  et  al.30 showed  an  improve-
ment in  renal  function,  including  urine  ﬂow  and  glomerular
ﬁltration in  the  postoperative  period.
One  of  the  most  likely  mechanisms  of  the  action  of
dexmedetomidine is  protecting  the  kidney  by  inhibiting  the
surgical stress  response  and  preventing  adrenergic  system-
mediated vasoconstriction.31--34 It  may  also  increase  renal
arterial vasodilation  through  direct  vascular  effects.19 PKC
has been  reported  to  play  an  important  role  in  ischemic
preconditioning and  to  open  sarcolemmal  and  mitochon-
drial ATP-dependent  K+ channels  by  stimulating  intracellular
transduction pathways  and  inducing  synthesis  of  protective
cellular proteins.  In  a  study  of  alternative  signal  transduc-
tion pathways,  alpha  2B  receptor  agonists  were  shown  to
stimulate PKC  activity  and  the  production  of  inositol  triphos-
phate in  the  distal  renal  collecting  tubule  cells,  suggesting
that alpha  2  agonists  mimic  cell  protection  by  IPC.35,36 Gu
et al.18 investigated  the  mechanism  of  action  of  dexmedeto-
midine in  vitro  with  a  stabilized  human  renal  proximal
tubule cell  culture  deprived  of  both  oxygen  and  glucose.
They reported  both  a  signiﬁcant  increase  in  phospho-
Akt expression  in  cultured  tubular  cells  after  treatment
with dexmedetomidine,  dependent  on  the  dose,  and  an
alpha-2 adrenoreceptor  effect.  The  phosphoAkt  path-
way ensures  cell  viability  by  inhibiting  caspase-controlled
intrinsic apoptotic  pathways  through  phosphorylation  of
proapoptotic Bcl-2,  which  triggers  cell  death,  and  upregula-
tion of  anti-apoptotic  Bcl-2  and  Bcl-XL  expression.
The  neuroprotective  effect  of  dexmedetomidine  has
been reported  to  be  a  result  of  the  increase  in  anti-apoptotic
Bcl-2 and  Mdm-2  expression;  this  increase  has  been  associ-
ated with  a  decrease  in  the  levels  of  proapoptotic  caspase-3
and Bax.37 The  Akt  pathway  is  critical  in  recovering  from
renal IR.  In  this  study,  as  an  indicator  of  apoptosis,  active
caspase-3 immunoreactivity  was  evaluated.  Activation  of
caspase-3 is  the  ﬁnal  step  of  apoptosis,  which  is  common  to
the two  major  pathways  of  apoptosis  and  a  deﬁnitive  indi-
cator of  cell  death.  Dexmedetomidine  administration  was
shown to  decrease  active  caspase-3  immunoreactivity,  but
not  signiﬁcantly  so  (p  =  0.06),  compared  with  IR  injury.
This statistically  non-signiﬁcant  difference  could  be
explained by  the  small  number  of  study  subjects.  Ischemic
preconditioning is  a  method  applied  mechanically  or  phar-
macologically prior  to  target  organ  ischemia  to  reduce
the level  of  subsequent  IR  injury.  The  aim  in  ischemic
preconditioning is  to  apply  ischemia  and  reperfusion  to  tar-
get organs  in  short  intervals,  to  ensure  that  the  target
organ(s) can  tolerate  ischemia  well.  High  energy  demands
and the  intense  microvascular  network  of  the  kidneys  make
them vulnerable  to  IR  injury,  which  is  considered  a  major
cause of  kidney  damage  in  renal  artery  stenosis  and  renal
microvascular surgery.  Renal  IR  injury  is  the  major  cause
of cardiovascular  morbidity  and  mortality,  and  is  associated
with post-transplantation  delay  in  graft  function,  and  renal
injury occurring  in  cardiac  and  aortic  surgery  and  post-shock
renal injury.1--4,38,39
Both  experimental  and  clinical  studies  in  the  literature
show that  distant  organ  IPC  may  be  protective  for  the
kidney.40,41 Similar  to  our  study,  Wever  et  al.40 investigated
the effect  of  hind  leg  DIPC  on  renal  IR  injury.  Differently,
these authors  compared  the  effect  of  administering  DIPCl  ischemia-reperfusion  389
ither  continuously  or  periodically,  and  also  to  one  or  two
xtremities. Although  they  performed  three  cycles  of  DIPC,
hey used  I/R  periods  of  4/4  min  and  investigated  the  even-
ual effects  of  25  min  of  ischemia.  They  reported  that
olecule-1 expression,  indicating  renal  tubular  and  renal
njury, decreased  signiﬁcantly  in  the  group  with  three  cycles
f I/R;  moreover,  this  protection  was  not  related  to  adeno-
ine, one  of  the  key  elements  in  I/R  injury.  The  underlying
echanism of  DIPC  and  its  transduction  pathways  are  not
et completely  understood.  Both  neurogenic  pathways  and
iochemical transmitters  may  play  roles  in  the  mechanism
f DIPC.42 These  mechanisms  may  vary,  depending  on  the
arget organ  and  applied  preconditioning  protocol.  In  the
yocardial ischemia  methods  using  renal  DIPC,  expression
f NF-B  protein  followed  by  the  opening  of  K+ ATP  channels
ave been  reported  to  be  important.43
Although  renal  IR  injury  is  a  common  and  important  clin-
cal problem,  strategies  to  reduce  IR  injury  are  insufﬁcient
nd new  treatments  are  needed.  In  the  literature,  no  report
f both  pharmacological  and  mechanical  protection  in  renal
R injury  in  rats  could  be  found.
Thus,  two  different  methods  used  in  rat  renal  IR  injury,
exmedetomidine, widely  reported  to  be  effective,  and
IPC, that  has  been  shown  to  be  effective  in  few  studies,11
ere  combined  and  compared.  Similar  to  dexmedetomidine,
sing dexmedetomidine  and  DIPC  in  combination  prevented
istopathological injury  and  improved  IR  injury  scores,
xcept tubular  change  scores,  to  levels  close  to  the  Sham
roup. At  the  same  time,  signiﬁcant  decreases  in  active
aspase-3 immunoreactivity  compared  with  the  IR  group
uggested that  using  dexmedetomidine  and  DIPC  in  com-
ination might  prevent  apoptosis.  Using  dexmedetomidine
lone decreased  active  caspase-3  immunoreactivity,  albeit
on-signiﬁcantly so,  which  suggests  that  these  two  methods
perate via  similar  pathways.  These  two  protective  methods
re likely  to  increase  the  effect  of  each  other.
In  our  study,  xylazine,  an  anesthetic  agent  having  alpha  2-
gonist activity,  and  ketamine42 suggested  to  have  negative
ffects on  IR  injury,  were  used.  Histopathological  scores  and
ctive caspase-3  immunoreactivity  were  normal  in  the  Sham
roup, which  suggests  that  ketamine  had  no  negative  effect
n our  results.
We did  not  show  the  effect  of  DIPC  alone  on  apoptosis,
hich plays  a  key  role  in  the  mechanism  of  IR  injury;  this  is
 limitation  of  the  present  study.  Other  limiting  factors  are
hat oxidative  stress  and  inﬂammatory  mediators,  which  are
lso responsible  for  IR  injury,  and  the  neurogenic  pathway,
ere not  examined.
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